Syneron Medical Ltd. (NASDAQ:ELOS) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: January 11, 2017
Having a price of $8.50, Syneron Medical Ltd. (NASDAQ:ELOS) traded -1.73% lower on the day. With the last stock price up 14.39% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.05% over the same period. ELOS has recorded a 50-day average of $8.32 and a two hundred day average of $7.43. Trade Volume was up over the average, with 183,350 shares of ELOS changing hands over the typical 169,240
Zacks Investment Research has downgraded Syneron Medical Ltd. (NASDAQ:ELOS) to Hold in a statement released on 1/11/2017.
On Thursday November 12, 2015, Leerink Swann released a statement about Syneron Medical Ltd. (NASDAQ:ELOS) dropped the target price from $16.00 to $9.00 that suggested an upside of 0.47%.
Recent Performance Chart
Syneron Medical Ltd. has PE ratio of 97.70 with a one year low of $6.11 and a one year high of $9.10 and has a market capitalization of $0.
General Company Details For Syneron Medical Ltd. (NASDAQ:ELOS)
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company designs, develops and markets aesthetic medical products based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. Its products target an array of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.